Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan

NCT01411423 · clinicaltrials.gov ↗

COMPLETED

Status

3305

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

DRUG: Sorafenib (Nexavar, BAY43-9006)

Sponsor

Bayer